Clinical trial / 2008
Caffeinated coffee raised serum caffeine levels and boosted the migratory capacity of endothelial progenitor cells in patients with coronary artery disease.
Researchers evaluated the effect of caffeine on endothelial repair using human cells, patients with coronary artery disease (CAD), and mouse models. In CAD patients, caffeinated coffee increased serum caffeine concentrations from 2 micromol/L to 23 micromol/L, which coincided with a significant increase in the migratory activity of patient-derived endothelial progenitor cells (EPCs). In contrast, decaffeinated coffee did not alter serum caffeine levels or EPC migratory capacity. Complementary animal and cell experiments demonstrated that caffeine enhanced reendothelialization in part through an AMPK-dependent mechanism.
- Study type
- Experimental study with human patient intervention and animal models
- Who was studied
- Patients with coronary artery disease (CAD)
- What was measured
- Caffeine serum concentration and migratory activity of patient-derived EPCs
THE PAPER
Caffeine enhances endothelial repair by an AMPK-dependent mechanism.
Spyridopoulos I, Fichtlscherer S, Popp R, Toennes SW, Fisslthaler B, Trepels T, Zernecke A, Liehn EA, Weber C, Zeiher AM, Dimmeler S, Haendeler J. Arterioscler Thromb Vasc Biol, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.